Abstract:Background: The increasing prevalence of allergies and asthma has led to a growing global socioeconomic burden. Since the outbreak of the COVID-19 pandemic, the health and lifestyles of children and adolescents have changed dramatically. It's unclear how this shift impacted allergy and asthma, with limited studies addressing this question. We aim to explore the difference of the prevalence of allergies and asthma among US children and adolescents during and before the COVID-19 pandemic using a nationally representative sample of US children and adolescents. Methods: This cross-sectional study included 31,503 participants in the National Health Interview Survey (NHIS) between 2018 and 2021. Allergies and asthma were defined on an affirmative response in the questionnaire by a parent or guardian. Chi-square tests were used to compare baseline characteristics with allergies and asthma for categorical variables. Differences in prevalence during and before the COVID-19 pandemic were estimated with weighted logistic regression, adjusting for demographic factors. Interaction analyses explored variations across strata. Results: In US children and adolescents aged 0 to 17, prevalence of any allergy was 26.1% (95% CI, 24.8%- 27.4%) in 2018 and 27.1% (95% CI, 25.9%- 28.2%) in 2021. Thereinto, in 2018, prevalence of respiratory allergies, food allergies and skin allergies were 14.0% (95% CI, 13.1%- 15.0%), 6.5% (95% CI, 5.8%- 7.1%) and 12.6% (95% CI, 11.6%- 13.5%), respectively, and in 2021, 18.8% (95% CI, 17.8%- 19.9%), 5.8% (95% CI, 5.2%- 6.4%) and 10.7% (95% CI, 9.9%- 11.5%), respectively. And prevalence of asthma was 11.1% (95% CI, 10.5%- 11.7%) in 2018-2019 and 9.8% (95% CI, 9.2%- 10.4%) in 2020-2021. Prevalence of respiratory allergies, skin allergies and asthma during and before the COVID-19 pandemic in children and adolescents had statistically significant differences. The differences persisted after adjusting for demographic and socioeconomic variables. Conclusion: Prevalence of respiratory allergies increased and the prevalence of both skin allergies and asthma decreased among US children and adolescents during the COVID-19 pandemic compared with the pre-COVID-19 pandemic. Further research is required to explore the association between allergic diseases and the pandemic, with a particular emphasis on the impact of lifestyle changes resulting from measures to prevent COVID-19 infection.

Association between allergic conditions and COVID-19 susceptibility and outcomes

The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19

Impact of Allergic Rhinitis and Asthma on COVID-19 Infection, Hospitalization, and Mortality

Asthma Disease Status, COPD, and COVID-19 Severity in a Large Multiethnic Population

How does allergic rhinitis impact the severity of COVID-19?: a case–control study

Asthma Phenotypes and COVID-19 Risk: A Population-based Observational Study

Allergic disease as a causal protective factor for severe covid-19: a multivariable mendelian randomization study

Non-Causal Effects of Asthma on COVID-19 Susceptibility and Severity

Asthma as a risk factor and allergic rhinitis as a protective factor for COVID-19 severity: a case-control study

Significant association between asthma and a lower risk of mortality among COVID-19 patients in Spain: A meta-analysis.

Recent advances and developments in COVID-19 in the context of allergic diseases

Impacts of Comorbidities on Annual Incidence and Frequency of Asthma Exacerbation Hospitalisation: Data from CARN Study

Prevalence of Comorbid Asthma and Related Outcomes in COVID-19: A Systematic Review and Meta-Analysis

Incident allergic diseases in post-COVID-19 condition: multinational cohort studies from South Korea, Japan and the UK

Associations Between Comorbidities and Annual Incidence Plus Frequency of Asthma Exacerbation Hospitalisation During the Past Year: Data from CARN Study

Potential Protective Factors for Allergic Rhinitis Patients Infected with COVID-19

Allergic diseases aggravate the symptoms of SARS-CoV-2 infection in China

Comorbid Asthma Decreased the Risk for COVID-19 Mortality in the United Kingdom: Evidence Based on a Meta-Analysis

Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19

Predictors of COVID-19 Infection: A Prevalence Study of Hospitalized Patients

Differences in the prevalence of allergy and asthma among US children and adolescents during and before the COVID-19 pandemic